NovaBay Pharma (NBY) Announces $3M Convertible Note Financing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
NovaBay Pharmaceuticals Announces $3.0 Million Convertible Note Financing
April 27, 2023 4:47 PM EDTEMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (NovaBay or the Company) announced today that it has entered into a securities purchase agreement with institutional accredited investors (Purchasers) in connection with a private placement to issue secured senior convertible debentures (the Debentures) and two series of new warrants exercisable for NovaBay common stock (the Warrants). The private placement is expected to close upon the satisfaction of closing conditions in the securities purchase agreement, which is expected to occur on or about May 1, 2023 or as soon as practicable thereafter. NovaBay intends to use the net proceeds... More
